Accessibility Menu
Eisai Stock Quote

Eisai (OTC: ESALF)

$30.37
(0.0%)
+0.01
Price as of October 15, 2025, 1:49 p.m. ET

KEY DATA POINTS

Current Price
$30.37
Daily Change
(0.0%) +$0.01
Day's Range
$30.37 - $30.37
Previous Close
$30.37
Open
$30.37
Beta
0.07
Volume
118
Average Volume
1,278
Market Cap
8.6B
Market Cap / Employee
$30.37M
52wk Range
$22.51 - $35.83
Revenue
-
Gross Margin
0.79%
Dividend Yield
3.54%
EPS
$1.19
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Eisai Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ESALF-11.42%-58.2%-15.99%+55%
S&P+14.84%+96.04%+14.41%+586%

Eisai Company Info

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$1.40B15.6%
Gross Profit$1.11B15.6%
Gross Margin78.98%0.0%
Market Cap$8.27B-33.4%
Market Cap / Employee$0.76M0.0%
Employees10.9K-1.4%
Net Income$106.15M43.7%
EBITDA$213.11M83.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$1.98B4.6%
Accounts Receivable$1.52B19.3%
Inventory1.6K32.8%

Liabilities

Q2 2025YOY Change
Long Term Debt$691.20M-17.5%
Short Term Debt$962.85M225.7%

Ratios

Q2 2025YOY Change
Return On Assets3.63%1.2%
Return On Invested Capital5.24%-2.4%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$23.81M69.5%
Operating Free Cash Flow$7.57M113.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings39.2320.1825.7824.06-55.53%
Price to Book1.911.261.441.47-31.50%
Price to Sales2.111.491.511.51-36.80%
Price to Tangible Book Value3.052.002.302.32-31.58%
Enterprise Value to EBITDA58.3435.38254.2537.29-61.17%
Return on Equity4.7%6.8%5.3%6.0%56.67%
Total Debt$1.28B$1.39B$1.55B$1.65B45.93%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.